We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Surrozen Inc is a class of therapeutics to treat serious diseases characterized by tissue injury. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), and SZN-043 (E3/ASGR1, SWEETS). Surrozen Inc is a class of therapeutics to treat serious diseases characterized by tissue injury. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), and SZN-043 (E3/ASGR1, SWEETS).
In a preclinical model of pulmonary fibrosis, a Surrozen antibody-based SWAP platform molecule decreased pulmonary inflammation and fibrosis and improved lung function Surrozen Wnt mimetic SWAP...
-Phase 1a trial demonstrated acceptable safety and tolerability with no reported serious adverse events-Phase 1a data demonstrated target engagement, a pharmacodynamic effect and effects on liver...
- $17.5 million upfront proceeds with up to an additional $175 million of proceeds upon the exercise of warrants- Initial capital funds expansion of Phase 1b trial in severe alcohol-associated...
Announces strategic prioritization of clinical programs to focus on development of SZN-043 for Alcohol-Associated Hepatitis SZN-043- Completed enrollment for the Phase 1a clinical trial in...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.4701 | -4.9746031746 | 9.45 | 9.8369 | 8.14 | 5472 | 9.03476772 | CS |
4 | -5.3201 | -37.2034965035 | 14.3 | 14.9598 | 8.14 | 28180 | 10.19957364 | CS |
12 | 0.9399 | 11.6902985075 | 8.04 | 16.19 | 7.7099 | 17690 | 11.18729886 | CS |
26 | 2.3799 | 36.0590909091 | 6.6 | 16.19 | 4.5 | 46821 | 7.52277318 | CS |
52 | -0.3306 | -3.55082970839 | 9.3105 | 16.19 | 4.5 | 73078 | 8.56599117 | CS |
156 | -134.2701 | -93.7313089005 | 143.25 | 210 | 4.5 | 181746 | 31.18948899 | CS |
260 | -134.2701 | -93.7313089005 | 143.25 | 210 | 4.5 | 181746 | 31.18948899 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions